Terns Pharmaceuticals

Terns Pharmaceuticals is a global biopharmaceutical company dedicated to the research and development of molecularly targeted, orally administered small-molecule innovative drugs for the treatment of liver diseases and cancer. Headquartered in San Mateo, California, and Shanghai, China (Terns China Biotechnology), Terns' long-term goal is to develop safe and effective combination therapies for patients with NASH and liver fibrosis.